Effect of Psoas myofascial release in nonspecific low back pai

Not Applicable

Recruiting

Conditions: onspecific chronic low back pain.
Low back pain
M54.5

Registration Number: IRCT20201108049305N1

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

18_60 years old patient with diagnosed nonspecific chronic low back pain
Pain in lumbar region, at least since 3 months ago
Score 3_7 in Visual Analog Scale
Disability index score of 4_8 in Roland-Morris disability questionnaire
Having enough literacy for filling the questionnaire
Having at least two parameters of tree following conditions:
- Positive modified Thomas test, at least in one side of pelvic
- Tenderness due to pressure on Psoas muscle, at least in one side of pelvic
- Producing pain and uncomfortable due to Psoas muscle maximum contraction, at least in one side of pelvic

Exclusion Criteria

Pregnancy
BMI score more than 30
History of lumbar spine surgery
Low back pain due to serious spinal pathology such as tumor, infection, inflammatory disorders
Symptoms of disc herniation (reduction of lower extremity force, reduction of reflexes of lower extremity, positive Straight Leg Raise test in less than 45 degrees.
No pain reduction in rest, No pain increasing with activity
History of fracture in spinal region
History of recent trauma to spine
Pain in resting
Joint disorders such as Rheumatoid Arthritis
Lumbar vertebral Spondylolisthesis
Using paregoric and muscle relaxant medicine in past 48 hours before assessment
Fibromyalgia
History of myofascial or rehabilitation treatment in past 2 months

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score. Timepoint: Before starting the treatment, 1day and 4 weeks after the end of treatment. Method of measurement: Visual Analog Scale.;Disability index. Timepoint: Before starting the treatment, 1day and 4 weeks after the end of treatment. Method of measurement: Roland-Morris Disability Questionnaire.

Secondary Outcome Measures